HFA Premium Access

Hypertrophic cardiomyopathy in female patients is associated with symptomatic heart failure and worse functional and exercise capacity

Congress Presentation

About the speaker

Doctor Yishay Wasserstrum

Sheba Medical Center, Ramat Gan (Israel)
0 follower

6 more presentations in this session

Patient-reported outcome measures in wild-type and variant cardiac transthyretin amyloidosis: the ITALY (impact of transthyretin amyloidosis on life quality) study

Speaker: Doctor A. Aimo (Pisa, IT)

Thumbnail

Echocardiography machine learning based to improve detection of transthyretin cardiac amyloidosis: the R3M algorithm

Speaker: Doctor A. Fraix (Nancy, FR)

Thumbnail

Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.

Speaker: Doctor T. Muresan (Paris, FR)

Thumbnail

Relative apical longitudinal strain: a powerful tool to predict outcomes in transthyretin amyloid cardiomyopathy

Speaker: Doctor M. Castro (Guimaraes, PT)

Thumbnail

A novel myocardium functional echocardiographic parameter, left ventricular myocardial work, associates with sudden cardiac risk score in patients with hypertrophic cardiomyopathy

Speaker: Doctor G. Racz (Szeged, HU)

Thumbnail

Access the full session

Myocardial disease - hypertrophic cardiomyopathy 3

Speakers: Doctor Y. Wasserstrum, Doctor A. Aimo, Doctor A. Fraix, Doctor T. Muresan, Doctor M. Castro...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations